Brigette B.Y. Ma, Francis Lee Professor, Director of Phase 1 Clinical Trial Centre, Department of Clinical Oncology, The Chinese University of Hong Kong, shared a post on LinkedIn:
“What a great start to Day 1 of 2nd annual ESMO TAT Asia, the premier early drug development forum in APAC designed for clinical investigators, scientists, pharmas , biotechs and investors of the region to come together and exchange!
We have nearly 600 attendees this year and KOLs speakers and many exciting presentations!
Our keynote speaker Prof Rui-Wa Xu president of Sun Yat Sen cancer center, China, gave a brilliant overview at our keynote lecture presided by both ESMO president and president elect Prof Curigliano and Prof Andres, of exciting developments in the fight against stomach cancer.
We hope to bring the latest advances in drug development in APAC to the world!”
Other articles featuring Brigette B.Y. Ma on OncoDaily.
